Biobanking, identification of biomarkers and the study on immune system in patients with multiple sclerosis

• Conditions: multiple sclerosis; MS; 10003816; 10012303

• Registration Number: NL-OMON37545
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

-Individuals must be at least 18 years old and able to give informed consent.
-Individuals must have one of the diagnoses: clinically isolated syndrom, relapsing-remitting MS, primary progressive MS, secondary progressive MS, neuromyelitis optica, transverse myelitis, and radiologically isolated syndrome.
-Individuals must be willing and able to provide blood and/or cerebrospinal fluid in addtion to requirement for clinical analysis

Exclusion Criteria

-Patients currently diagnosed with an autoimmune disorder other than MS.
-Patients with ongoing bacterial, viral, or fungal infection.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable </p><br>